With our in-house technology platform, scientific expertise in the inner ear, and network of experts, Sensorion can continually develop and optimize its pipeline and market expertise. Consequently, we are poised to expand our pipeline and facilitate other pharmaceutical collaborations.

We select and develop drug candidates from a pool of compounds in late pre-clinical and clinical stage development obtained from partnerships, collaborations and publically available drug libraries.

Sensorion has two therapeutic solutions being evaluated in clinical trials:
SENS-111 and SENS-401

2018 08 Pipeline

Latest news

  • 13 Feb 2019

    Sensorion to present new SENS-401 data at ARO 2019 MidWinter Meeting, Feb. 9-13, 2019. Read

  • 07 Jan 2019

    Bilan semestriel du contrat de liquidité Sensorion avec la société de bourse Kepler Cheuvreux. Read (in french only)

Patient center

Corporate presentation